Mark Hudson | Senior Manager, Investor Relations |
Leonard Schleifer | Founder, President & Chief Executive Officer |
George Yancopoulos | Founding Scientist, President & Chief Scientific Officer |
Marion McCourt | Senior Vice President & Head of Commercial |
Bob Landry | Executive Vice President & Chief Financial Officer |
Terence Flynn | Goldman Sachs |
Cory Kasimov | JPMorgan |
Carter Gould | UBS |
Greg Harrison | Barclays |
Geoffrey Porges | SVB Leerink |
Matthew Harrison | Morgan Stanley |
Ying Huang | Bank of America |
Matthew Luchini | BMO |
Brian Skorney | Baird |
Alethia Young | Cantor Fitzgerald |
Good morning and welcome to the Regeneron Pharmaceuticals First Quarter 2019 Earnings Conference Call. My name is Brandon and I will be your operator for today’s call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] Please note that this conference is being recorded.